Accurate coding for covid 19 exposure is essential for clinical clarity, legal compliance, and correct reimbursement. Coders and billers must distinguish encounters that document potential exposure from those that document confirmed infection, screening, or history. Misclassification can lead to claim denials, incorrect risk adjustment, and audit exceptions.
This article explains what Contact with and (suspected) exposure to COVID-19 represents clinically, when to assign the code, common exclusions, related codes, and pragmatic billing and documentation strategies. It offers actionable guidance for revenue cycle managers, coders, and clinicians to improve first-pass accuracy and reduce denials.
The ICD-10-CM Code for Contact with and (suspected) exposure to COVID-19 is Z20.822.
Contact with and (suspected) exposure to COVID-19 describes an encounter where a patient has been in contact with someone known or suspected to have COVID-19 but the patient does not have a confirmed diagnosis of COVID-19 at the time of the encounter. Clinically, this includes asymptomatic or symptomatic patients who present because of known exposure (household contact, workplace exposure, close contact in a healthcare setting, etc.), when testing is pending, refused, or not yet performed, and no definitive diagnostic code has been assigned. In ICD-10-CM classification, Z20.822 is a Z-code used to capture the reason for encounter—exposure risk—rather than an active infectious disease diagnosis.
Use Contact with and (suspected) exposure to COVID-19 when a patient reports living with or having direct prolonged contact with a household member who tested positive for COVID-19 and the visit is for risk assessment, counseling, quarantine instructions, or testing, without a confirmed infection in the patient.
When an employee reports a documented exposure to a COVID-19 positive patient or co-worker (for instance, unprotected exposure during aerosol-generating procedures) and the encounter is for occupational health evaluation, post-exposure testing, or return-to-work guidance without confirmed infection, code Contact with and (suspected) exposure to COVID-19.
If a patient is symptomatic or asymptomatic following a known exposure and testing has been ordered but results are pending—or testing is negative and the clinician has not established a diagnosis of COVID-19—use Contact with and (suspected) exposure to COVID-19 to reflect exposure risk in the medical record and claims.
Use Contact with and (suspected) exposure to COVID-19 for encounters resulting from public health contact tracing when the patient is identified as a contact, assessed for symptoms, and provided instructions or testing but not diagnosed with COVID-19.
Do not use Contact with and (suspected) exposure to COVID-19 when the patient has a confirmed COVID-19 infection. Instead, code the confirmed diagnosis of COVID-19 (e.g., U07.1) as the principal diagnosis and document associated manifestations as appropriate.
If the visit is for population screening or asymptomatic screening without a known contact or specific exposure risk, do not use Contact with and (suspected) exposure to COVID-19; use the appropriate screening code (for example, an encounter-for-screening code when available) instead.
Do not use Contact with and (suspected) exposure to COVID-19 if documentation specifies a different exposure type or result—such as an adverse reaction to a vaccine or post-COVID sequelae. Use the specific code that captures the documented condition or history.
If the record reflects observation for suspected infection where COVID-19 has been ruled out and a different diagnosis is established, do not code Contact with and (suspected) exposure to COVID-19; instead assign codes for the confirmed diagnosis or observation outcome.
| Condition | Code | When It Is Used | When It Is Not Used |
|---|---|---|---|
| Contact with and (suspected) exposure to COVID-19 | Z20.822 | Use when patient has known or suspected exposure to COVID-19 without a confirmed diagnosis; for counseling, testing pending, occupational assessment, or public health contact tracing. | Do not use when COVID-19 is confirmed (use U07.1), when encounter is routine screening without exposure, or when a more specific condition is documented. |
| COVID-19, virus identified | U07.1 | Use when laboratory testing or clinician documents confirmed COVID-19 infection as the diagnosis for the encounter; applicable for symptomatic or asymptomatic confirmed cases. | Do not use for exposure-only encounters, screening without confirmed infection, or history of prior infection without current disease. |
| Contact with and (suspected) exposure to other viral communicable diseases | Z20.828 | Use for known or suspected contact with non-COVID viral communicable diseases when exposure risk is the reason for the encounter. | Do not use for COVID-19 exposures (use Z20.822) or for confirmed infections of other viruses. |
| Encounter for screening for COVID-19 | Z11.52 | Use for asymptomatic screening when no specific exposure is documented but screening is performed for surveillance, pre-procedure, or institutional requirements. | Do not use when there is documented exposure (use Z20.822) or when infection is confirmed (use U07.1). |
Record who was exposed (household member, coworker, patient), timing, proximity, and whether exposure was confirmed or suspected. Payers and auditors look for explicit exposure descriptors to support Z20.822.
Clinicians should state whether the visit is for exposure evaluation, screening, or treatment of confirmed COVID-19. Coders need clear documentation to select Z20.822 versus screening codes or U07.1.
Tie tests, telehealth visits, or isolation counseling to the documented exposure. For reimbursement and audit defense, document the clinical rationale that supports ordered services as medically necessary for the exposure encounter.
Leverage CombineHealth.ai's AI-powered platform and its claim scrubbing and coding validation features to catch mismatches—such as assigning exposure codes when U07.1 is present—and to improve first-pass acceptance rates.
Provide concise templates or EHR prompts for exposure-related visits to capture exposure details, symptom status, tests ordered, and clinician assessment. Consistent documentation reduces coding ambiguity and denials.
Coding for covid 19 exposure has direct impact on revenue cycle outcomes:
Accurate ICD-10 coding is critical for healthcare revenue cycle performance. CombineHealth.ai's AI-powered platform helps RCM teams ensure coding accuracy, reduce denials, and optimize reimbursement through intelligent denial management and claim validation. CombineHealth.ai's intelligent platform provides automated claim scrubbing and coding validation to catch errors before submission, reducing denials and improving first-pass acceptance rates.
Q1: What is the ICD-10 code for covid 19 exposure?
The ICD-10-CM code for covid 19 exposure is Z20.822. This code documents that a patient had contact with or suspected exposure to COVID-19 without a confirmed infection at the time of the encounter.
Q2: When should I use Z20.822 vs related codes?
Use Contact with and (suspected) exposure to COVID-19 for exposure-only encounters. Use U07.1 for confirmed COVID-19 infection. Use screening codes when there is no documented exposure but testing is performed for surveillance or pre-procedure purposes. Select codes based on the documented clinical scenario, not presumptions.
Q3: What documentation is required when coding for covid 19 exposure?
Document the exposure source and timing, patient symptom status, tests ordered and results (or pending status), clinician assessment and plan, and any work- or public-health-related instructions. Clear linkage between documentation and services billed supports medical necessity.
Q4: What are common denial reasons when coding for covid 19 exposure?
Common denials include using Z20.822 when infection is confirmed, insufficient exposure documentation, lack of linkage to billed services, and payer-specific exclusions for screening versus exposure. For denial prevention strategies, see our guide on denial management.